Purchase Order FA864923P0777
Award Date 5/12/23
Potential Completion Date 8/10/23
Potential Value $75K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Princeton, NJ, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
999
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- Cytosorbents Medical Inc., doing business as Cytosorbents, was awarded a $999,070.00 Small Business Innovation Research (SBIR) Phase II contract by the Department of the Army Medical Command. The contract is for the development of medical devices and technologies, including an extracorporeal cytokine adsorber to treat septic shock, a potassium adsorber to treat hyperkalemia, and an adsorber to remove anti-A and anti-B antibodies from blood for transfusion. Cytosorbents is the prime contractor...
- Cytosorbents Medical Inc., doing business as Cytosorbents, was awarded a $2.9 million firm fixed price contract from the Department of the Army Medical Command to develop a highly efficient adsorber to remove anti-A and anti-B antibodies from blood and plasma for transfusion under a Small Business Technology Transfer Research Phase III solicitation. This definitive contract is a follow-on to previous STTR research awards and will support Cytosorbents' continued medical research and development...
- This contract was awarded by the Department of the Army Medical Command to Cytosorbents Medical Inc., doing business as Cytosorbents, a for-profit small business manufacturer of medical devices and technologies. The $999,871.34 fixed-price level of effort contract is for Phase II of a Small Business Innovation Research (SBIR) project to develop blood purification technologies. Cytosorbents, as the prime contractor, is providing research and prototype development services to the Defense Health...
- This federal contract award, with a ceiling value of $149,927.17, was issued by the U.S. Medical Command (MEDCOM) to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for a SBIR Phase I research project under the Defense Health Program (DHP), with the goal of developing an extracorporeal cytokine adsorber to treat septic shock. As a small business set-aside, Cytosorbents is the prime contractor responsible for conducting the research to...
- This is a $999,996.59 firm-fixed-price Phase II SBIR contract awarded by the Joint PEO Chemical and Biological Defense to Cytosorbents Medical Inc., a small business manufacturer of medical devices and technologies. The contract is for research and prototype development services related to Cytosorbents' blood purification technologies, including an extracorporeal cytokine adsorber, a potassium adsorber, and a blood group antibody adsorber. These technologies are intended to treat critical care...
- The Air Force has awarded a $2,959,747 cost-plus-fixed-fee contract to Cytosorbents Medical Inc. to provide the K+ONTROL Renal Support System for Reduction of Hyperkalemia. This definitive contract has an ultimate completion date of September 27, 2023. Cytosorbents is a for-profit manufacturer that develops blood purification technologies to treat critical care conditions. The company has previously received research and development funding from the National Institutes of Health and Department...
- The U.S. Army Medical Command awarded a $4.3M Phase III Small Business Innovation Research (SBIR) contract to Cytosorbents Medical Inc. on August 22, 2022, for research and development of a universal dried plasma product designed for battlefield and first responder use. The contract, which carries a firm fixed-price structure and is set aside for small business, focuses on integrating isoagglutinin reduction technology to enable universal blood transfusions in emergency and combat scenarios....
- This federal contract award was made by the National Heart Lung and Blood Institute, a civilian agency, to Cytobank, Inc., a small business, for a SBIR Phase I project titled "A Cloud Computing Platform for Cytometry." The $153,813 Firm Fixed Price contract was awarded on September 23, 2011 with a completion date of March 22, 2012. The project falls under the SBIR (Small Business Innovation Research) program, which supports research and development by small businesses. This Phase I...
- The Department of the Air Force Materiel Command Research Laboratory awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Securisyn Medical, LLC, a self-certified small disadvantaged business. The $158,000.00 firm fixed price contract is for research and development related to oxygen delivery systems and endotracheal tube securement products to prevent dislodgement among battlefield airmen. Securisyn Medical has previously provided research, development, testing, and...
- The Department of the Army Medical Command awarded a $166,492.05 Small Business Innovation Research (SBIR) Phase I contract to CFD Research Corporation, doing business as CFD Research, for the development of a "Portable Automated Phage Isolation Technology." This firm-fixed-price contract was set aside for small businesses. CFD Research, a for-profit engineering and technology services firm, has a history of providing computational fluid dynamics research, artificial intelligence,...